Medication Assisted Treatment Rehab: What Families Should Know

Medication assisted treatment rehab pairs FDA-approved medicines with structured therapy so the brain can stabilize while you rebuild daily life. At Faith Recovery Center in Beverly Hills, that model sits inside a full continuum of care: medical detox, residential treatment, PHP, IOP, and aftercare, with physician and psychiatrist support for dual diagnosis from day one.

If you or someone you love is facing opioid use disorder or alcohol use disorder, you deserve clear facts, not slogans. This guide explains what medication-assisted treatment is, which medications for opioid and alcohol problems clinicians use, how dosing works, and how our admissions team helps you verify benefits and start care without pressure.

What Is Medication-Assisted Treatment?

Medication-assisted treatment, in plain terms, is a whole-patient approach that combines FDA-approved medications with counseling and behavioral therapies rather than relying on a pill alone. At Faith Recovery Center in Beverly Hills, that model runs under physician and psychiatrist oversight inside an eight-patient program. Clinicians often shorten the model to treatment MAT when they discuss protocols with patients and family members.

Medication assisted treatment is not a shortcut around recovery work. Therapeutic doses help normalize brain chemistry, reduce cravings and withdrawal, and blunt euphoric effects so therapy can stick. Many medical professionals compare it to treating a chronic condition such as diabetes: medicine plus lifestyle change, not medicine instead of change.

Across the United States, federal agencies including the Substance Abuse and Mental Health Services Administration publish guidance on prevention and treatment standards for substance use disorder. You can review public materials at SAMHSA and research summaries from the National Institutes of Health when you want primary-source context.

How Does MAT Work on Opioid Receptors?

MAT changes the effects of opioids in the body through three main medication actions on opioid receptors, the same receptor targets clinicians monitor in Faith Recovery Center medical protocols. A full opioid agonist such as methadone occupies receptors strongly enough to prevent withdrawal symptoms and reduce illicit use when dosed correctly. A partial opioid agonist such as buprenorphine activates receptors enough to ease opioid dependence without the same ceiling for respiratory depression risk at therapeutic ranges.

Antagonist medicines such as naltrexone Vivitrol formulations block opioid activity so that taking opioids produces little or no high. In short, MAT medications either occupy, partially activate, or block opioid receptors so cravings and withdrawal ease and euphoric effects lose their pull. That chemistry creates room for behavioral therapy, relapse-prevention skills, and recovery support.

MAT does not replace one addiction with another. At proper doses, patients do not chase a misuse high. The goal is stability so each patient can engage in counseling and behavioral work, sleep, eat, and plan a life after discharge.

Medications for Opioid Use Disorder and Alcohol Addiction

FDA-approved medications used to treat opioid dependence

Three primary FDA approved options guide treatment of OUD in clinical settings: methadone and buprenorphine, plus extended-release naltrexone. Methadone and buprenorphine are recognized internationally as essential medicines for opioid dependence. OUD methadone programs historically required specialized clinics. Buprenorphine expanded office-based opioid treatment when regulations allowed trained clinicians to prescribe it.

Buprenorphine comes in sublingual films or tablets and in long-acting injectable forms. A monthly injection can help people who struggle with a daily dosing schedule. Naltrexone Vivitrol is also available as a monthly injection after full detox, which matters because starting too early can precipitate withdrawal.

MAT for opioid care also pairs with overdose tools. Naloxone and related opioid overdose reversal medicines are a core companion to any serious opioid response plan. Families should know how to use naloxone and keep it available while someone stabilizes.

MAT options for alcohol use disorder

Alcohol addiction responds to a different set of medicines inside structured clinical care. Naltrexone, acamprosate, and disulfiram are common choices for alcohol use disorder when clinically appropriate. These agents do not work like methadone and buprenorphine on opioid receptors. They target craving pathways, protracted withdrawal biology, or aversive responses to drinking.

People sometimes need support for both opioid and alcohol problems in the same episode of care. Integrated plans can address alcohol and opioid patterns together when assessment shows dual substance risk, always with medical oversight for withdrawal safety.

Opioid Use Disorder, Fentanyl, and Why Access Still Lags

Opioid use disorder is a medical condition marked by compulsive use despite harm, tolerance, and withdrawal. Synthetic opioids such as fentanyl raise overdose risk because potency varies and respiratory depression can hit fast. MAT can treat opioid addiction driven by fentanyl when induction is carefully timed and monitored. Clinicians adjust protocols because fentanyl’s staying power can complicate starts on buprenorphine.

Documented clinical benefits of medications for opioid use disorder include lower overdose risk, less illicit opioid misuse, stronger retention in care, and better social functioning among people who stay engaged. Public health reviews also link MAT with less criminal justice involvement and lower transmission of infections such as HIV and hepatitis C when people stop or reduce injection drug abuse.

Even with that evidence, many programs still do not offer full access to MAT, and capacity shortages leave eligible patients untreated. Stigma among policymakers, some providers, and communities remains a barrier. Technical assistance from federal partners aims to close those gaps, yet technical assistance alone cannot staff every clinic. Coastal cities and inland metros, including Atlanta GA service areas, still report wait lists. Families in Atlanta GA and elsewhere often search far from home when local beds or buprenorphine prescribers are scarce. National technical assistance centers publish toolkits, and state agencies request technical assistance to expand opioid treatment slots, but demand still outruns supply in much of the United States.

Faith Recovery Center keeps MAT inside a boutique behavioral health setting rather than a high-volume corridor model. We cannot solve every national capacity gap, and we do not claim multi-state clinics. We can offer intimate, physician-led opioid treatment and dual-diagnosis care for a maximum of eight patients at a time in Beverly Hills.

Medication Assisted Treatment Rehab at Faith Recovery Center

Our medication assisted treatment rehab pathway sits inside one licensed estate at 2200 Coldwater Canyon Dr, Beverly Hills, CA 90210. You move through detox, residential, and outpatient levels without losing your clinical team when step-down is appropriate. Joint Commission accreditation, California DHCS licensing, and LegitScript certification anchor our standards.

Dr. Jason Giles, M.D., a board-certified physician with deep addiction-medicine experience, oversees medical and MAT-related protocols. Dr. Julio Meza, M.D., a licensed psychiatrist, integrates care for co-occurring mental health conditions such as anxiety, depression, PTSD, bipolar disorder, ADHD, and related mental illness. That pairing matters because substance abuse and mental health needs rarely travel alone.

Private suites, chef-prepared meals, 24/7 clinical support, and an eight-patient maximum mean the team knows each patient’s history and goals. Treatment programs blend CBT, DBT, EMDR, trauma-informed care, group work, family therapy, yoga, art therapy, life skills, and relapse-prevention planning. Medication is one tool inside individualized treatment plans, never the only tool.

We treat a full spectrum of drug alcohol concerns, including opioids, stimulants, benzodiazepines, and alcohol abuse, with medical detox when physical dependence requires monitoring. Length of stay is individualized. Detox timing depends on medical need. Residential care commonly lasts thirty days or longer. Outpatient PHP or IOP often continues for months based on progress.

Behavioral Health Integration and Dual Diagnosis Care

Behavioral health care fails when substance use and mental health tracks never speak to each other. Substance abuse and mental illness frequently co-occur, and untreated psychiatric symptoms drive relapse. Our model assesses mental health on arrival and continues psychiatric follow-up throughout the stay when indicated.

Substance abuse and mental health education for family members helps loved ones separate enabling from support. We schedule family therapy after initial stabilization and teach practical recovery support skills. Substance use and mental health goals appear on the same plan so medicines, therapy hours, and sleep routines reinforce one another.

Evidence-based strategies include motivational interviewing, skills groups, and trauma work alongside MAT when indicated. Patients who prefer non-medication pathways after a full assessment can still receive structured addiction treatment. Choice belongs with the clinical team and the person in care, not a one-size protocol.

Inpatient Rehab, Outpatient Steps, and Long-Term Recovery

Inpatient rehab at our manor gives full separation from triggers while medical staff manage dosing schedule changes, side effects, and early recovery sleep disruption. People step into PHP or IOP when they need structure but can handle more independence. Aftercare planning before discharge covers therapy referrals, medication follow-up, and sober supports so long-term recovery has a written map.

Long-term recovery is rarely a straight line. Some people stay on MAT medications for months. Others taper under supervision after stability returns. Either path can support addiction recovery when counseling continues and overdose risk education stays current. Recovery centers that refuse MAT entirely leave some patients without a tool that lowers the risk of death after relapse. We discuss treatment options openly so you can weigh medication-assisted and non-medication routes with facts.

Opioid treatment programs and primary care clinics across the United States can integrate medications for opioid use disorder with broader services. Boutique recovery centers like ours add privacy, dual-diagnosis depth, and hospitality without diluting clinical rigor. Other recovery centers may specialize only in outpatient starts. Compare staffing, accreditation, and whether plans cover the full continuum you need.

Health Insurance, Cost, and How Plans Cover MAT

Many private PPO health insurance plans cover MAT when it is medically necessary, though benefits vary by contract. Our team offers free confidential insurance verification before you commit. We commonly work with Aetna, Anthem, Blue Cross Blue Shield, Cigna, UnitedHealthcare, Optum, Humana, Highmark, and most major PPO plans. Some stays are largely covered. Private pay remains available when benefits are limited.

Ask whether your insurance plans include residential days, outpatient hours, and pharmacy benefits for MAT medications. Pharmacy tiers and prior authorization rules can affect methadone and buprenorphine access after discharge. Our admissions team walks through those details so you are not guessing at the pharmacy counter.

Federal law treats addiction treatment as a covered health benefit in many marketplace plans, yet network rules still matter. Call (844) 598-5573 for free confidential benefits review any time. No doctor referral is required to start the conversation.

Technical Assistance, Public Resources, and National Context

Providers expanding MAT often rely on technical assistance from the Substance Abuse and Mental Health Services Administration and related partners. That technical assistance may cover induction protocols, diversion control, and integration with primary health care. Communities facing high opioid use disorder rates request technical assistance to train clinicians and reduce stigma in local systems.

Patients do not need to work through technical assistance bureaucracies to get help. Your job is to reach a licensed program. Still, knowing that national technical assistance exists explains why standards keep improving even while access gaps remain. Public pages at https://www.samhsa.gov/ outline helplines, grant programs, and clinician resources tied to prevention and treatment.

SAMHSA’s National Helpline is a free confidential 24/7 information service for people and family members facing mental health or substance use concerns. It can point callers toward local resources when they are not yet ready for a specific facility. For research-backed overviews of opioid use disorder biology, the National Institutes of Health and its institutes remain primary references.

Family Members and Practical Support During Care

Family members often make the first call. You can contact our admissions team on a loved one’s behalf, share medical history you know, and ask about visitation after stabilization. We outline family therapy opportunities at intake and keep communication boundaries clear under HIPAA.

Bring photo ID, insurance cards, medication lists, and emergency contacts when admission is set. Leave valuables, alcohol, and non-prescribed drugs at home. Comfortable clothing for a multi-week stay and prescribed medicines in original bottles help orientation go smoothly.

If work or school is a concern, the admissions team can discuss medical leave documentation. Ambivalence is normal. Multiple conversations before a decision are welcome.

Frequently Asked Questions About Medication Assisted Treatment

What does medication-assisted treatment mean for daily life?

It means taking a prescribed medicine on a set schedule while you attend therapy, rebuild routines, and address triggers. Daily films, clinic dosing, or a monthly injection are all possible formats depending on the agent and your plan. The medicine supports stability. Counseling and behavioral change drive long-term recovery.

How does MAT success compare with abstinence-only rehab?

For many people with opioid use disorder, adding appropriate medicine improves retention and lowers overdose risk compared with abstinence-only approaches that offer no receptor support. Results still depend on therapy quality, housing stability, and mental health care. We individualize rather than promise a single success percentage.

What side effects should I expect from buprenorphine treatment?

Common effects can include headache, nausea, constipation, sweating, or sleep changes, especially early on. Serious reactions are less common but require prompt medical contact. Your dosing schedule and formulation (sublingual versus injectable) influence how side effects feel. Report problems instead of stopping abruptly.

Can pregnant women safely receive medication-assisted treatment for opioids?

For pregnant or breastfeeding patients with opioid use disorder, MAT is widely preferred over unmanaged withdrawal because it can improve maternal and fetal outcomes when supervised. Methadone and buprenorphine are the agents most often discussed in perinatal guidelines. Decisions belong with obstetric and addiction specialists coordinating care.

Are there long-acting MAT injectables that avoid daily dosing?

Yes. Extended-release buprenorphine and naltrexone Vivitrol products can be given as a monthly injection after clinical criteria are met. Injectables help people who travel, dislike daily films, or need tighter adherence support. Not every patient is a candidate on day one.

Will MAT medications appear on employment drug screenings?

Standard panels sometimes detect opioids or related compounds, and confirmatory testing can identify prescribed methadone or buprenorphine. Lawful prescriptions and medical review officer processes matter. Discuss workplace policies with your clinician and HR before surprises arise. Privacy rules still apply to health care disclosures.

How do I transition safely from methadone to buprenorphine?

Cross-tapering requires medical supervision because starting buprenorphine too soon after a full opioid agonist can trigger precipitated withdrawal. Clinicians lower methadone, time the first buprenorphine dose, and monitor closely. Never attempt this switch on your own.

What happens if I miss a dose of my MAT medication?

Contact your prescribing team for instructions rather than doubling up. Missing doses can bring back withdrawal symptoms and cravings and raise overdose risk if illicit use returns. Clinic policies differ for methadone take-homes versus office-based buprenorphine.

Does MAT effectively treat fentanyl-specific opioid addiction?

Yes, MAT remains a primary treatment for opioid addiction involving fentanyl, though induction may need adjusted timing and monitoring. Fentanyl’s potency elevates overdose risk during any return to use, which is why naloxone education and structured therapy stay part of care beside medicine.

Can I travel internationally while on a methadone program?

International travel on methadone is complicated. Some countries restrict import of opioid agonist medicines, and guest-dosing arrangements take advance paperwork. Talk with your clinic weeks ahead. Buprenorphine or injectable options sometimes simplify travel when clinically appropriate.

Can adolescents under 18 qualify for medication-assisted treatment?

Some adolescents with opioid use disorder may qualify under specialist care, with stricter regulations and parental involvement depending on jurisdiction and medicine. Faith Recovery Center focuses on adult programming. Our admissions team can discuss fit and, when needed, help families locate age-appropriate referrals.

What are the medications used in MAT?

For opioid use disorder, the main FDA-approved medications are methadone, buprenorphine (including long-acting forms), and naltrexone. For alcohol addiction, naltrexone, acamprosate, and disulfiram are common. Overdose reversal agents accompany opioid-focused plans even though they are not daily maintenance medicines.

Ready to Talk About Treatment Options?

If medication assisted treatment rehab sounds like the right next step, or you still have questions about opioid or alcohol pathways, reach our admissions team at (844) 598-5573. We provide free confidential verification, clinical assessment, and often arrange arrival within 24–48 hours when beds and medical fit allow.

Faith Recovery Center delivers boutique behavioral health in a private Beverly Hills manor: eight patients maximum, private suites, 24/7 support, and integrated psychiatry for substance use disorder and co-occurring mental illness. Contact us when you are ready. We will meet you where you are and build a plan that fits the person, not a brochure.